Skip to main content

Risks and benefits of nanotechnology: How young adults perceive possible advances in nanomedicine compared with conventional treatments

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Attitudes to nanotechnology are widely studied and are changing fast. An experiment comparing young peoples' attitudes to nanomedicine and conventional treatment was conducted on 434 undergraduate students. They answered a number of questions about a hypothetical arthritis sufferer who was to be treated with a drug or a newly invented nanomedical technique, and requiring either one treatment or several. They were more influenced by the difference between one-shot and repeated treatments than by any difference between drug- and nanodelivery. Furthermore the two treatments that seemed most negative to participants were a drug that had to be administered repeatedly, or a nanosystem that was needed only once. Participants preferred the thought of a drug that only had to be taken once, or else a nanosystem so gentle and progressive that it only took its full effect after several administrations. There was a consistent gender difference, with male participants taking a more positive view of the risks, benefits and achievements involved in the various treatments than the female participants.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: Nanotechnology; medicine; public understanding of science; risk; vignette study

Document Type: Research Article

Affiliations: 1: Institute for Science and Society, Biorisks and Society (IGBiS), University of Nottingham, Nottingham, UK 2: School of Psychology, University of Nottingham, Nottingham, UK 3: Division of Primary Care, University of Nottingham, Graduate Medical School, Derby City General Hospital, Derby, UK

Publication date: 2007-06-01

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more